Challenges	Challenge	NNS	B-NP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
control	control	NN	I-NP	O	
of	of	IN	B-PP	O	
gonorrhea	gonorrhea	NN	B-NP	O	
in	in	IN	B-PP	O	
South America	South_America	NNP	B-NP	O	
and	and	CC	O	O	
the	the	DT	B-NP	O	
Caribbean	Caribbean	NNP	I-NP	O	
:	:	:	O	O	
monitoring	monitor	VBG	B-VP	O	
the	the	DT	B-NP	O	
development	development	NN	I-NP	O	
of	of	IN	B-PP	O	
resistance	resistance	NN	B-NP	O	
to	to	TO	B-PP	O	
antibiotics	antibiotic	NNS	B-NP	O	
.	.	.	O	O	
:	:	:	O	O	
The	The	DT	B-NP	O	
objective	objective	NN	I-NP	O	
of	of	IN	B-PP	O	
this	this	DT	B-NP	O	
study	study	NN	I-NP	O	
was	be	VBD	B-VP	O	
to	to	TO	B-VP	O	
ascertain	ascertain	VB	I-VP	O	
the	the	DT	B-NP	O	
antimicrobial	antimicrobial	JJ	I-NP	O	
susceptibility	susceptibility	NN	I-NP	O	
of	of	IN	B-PP	O	
Neisseria gonorrhoeae	Neisseria_gonorrhoeae	NNP	B-NP	O	
isolates	isolate	NNS	I-NP	O	
from	from	IN	B-PP	O	
6	6	CD	B-NP	O	
South American	South_American	JJ	I-NP	O	
and	and	CC	I-NP	O	
13	13	CD	I-NP	O	
Caribbean	Caribbean	JJ	I-NP	O	
countries	country	NNS	I-NP	O	
participating	participate	VBG	B-VP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
Gonococcal	Gonococcal	NNP	I-NP	O	
Antimicrobial	Antimicrobial	NNP	I-NP	O	
Surveillance	Surveillance	NNP	I-NP	O	
Program	Program	NNP	I-NP	O	
(	(	(	O	O	
GASP	GASP	NN	B-NP	B-protein	
)	)	)	O	O	
from	from	IN	B-PP	O	
1990	1990	CD	B-NP	O	
to	to	TO	B-PP	O	
1999	1999	CD	B-NP	O	
.	.	.	O	O	
:	:	:	O	O	
A	A	DT	B-NP	O	
GASP	GASP	NN	I-NP	B-protein	
network	network	NN	I-NP	I-protein	
of	of	IN	B-PP	O	
laboratories	laboratory	NNS	B-NP	O	
was	be	VBD	B-VP	O	
launched	launch	VBN	I-VP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
Americas	Americas	NNP	I-NP	O	
and	and	CC	O	O	
the	the	DT	B-NP	O	
Caribbean	Caribbean	NNP	I-NP	O	
during	during	IN	B-PP	O	
the	the	DT	B-NP	O	
1990s	1990s	CD	I-NP	O	
.	.	.	O	O	

Standardized	Standardized	JJ	B-NP	O	
methods	method	NNS	I-NP	O	
and	and	CC	O	O	
interpretative	interpretative	JJ	B-NP	O	
criteria	criterion	NNS	I-NP	O	
were	be	VBD	B-VP	O	
established	establish	VBN	I-VP	O	
for	for	IN	B-PP	O	
the	the	DT	B-NP	O	
isolation	isolation	NN	I-NP	O	
of	of	IN	B-PP	O	
N. gonorrhoeae	N._gonorrhoeae	NNP	B-NP	O	
,	,	,	O	O	
strain	strain	NN	B-NP	O	
identification	identification	NN	I-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
determination	determination	NN	B-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
quality	quality	NN	B-NP	O	
control	control	NN	I-NP	O	
of	of	IN	B-PP	O	
antimicrobial	antimicrobial	JJ	B-NP	O	
susceptibility	susceptibility	NN	I-NP	O	
.	.	.	O	O	
:	:	:	O	O	
Two	Two	CD	B-NP	O	
countries	country	NNS	I-NP	O	
(	(	(	O	O	
Argentina	Argentina	NNP	B-NP	O	
and	and	CC	I-NP	O	
Uruguay	Uruguay	NNP	I-NP	O	
)	)	)	O	O	
maintained	maintain	VBD	B-VP	O	
continuous	continuous	JJ	B-NP	O	
surveillance	surveillance	NN	I-NP	O	
during	during	IN	B-PP	O	
the	the	DT	B-NP	O	
study	study	NN	I-NP	O	
period	period	NN	I-NP	O	
.	.	.	O	O	

Some	Some	DT	B-NP	O	
countries	country	NNS	I-NP	O	
gathered	gather	VBD	B-VP	O	
data	datum	NNS	B-NP	O	
periodically	periodically	RB	B-ADVP	O	
and	and	CC	O	O	
several	several	JJ	B-NP	O	
others	other	NNS	I-NP	O	
were	be	VBD	B-VP	O	
unable	unable	JJ	B-ADJP	O	
to	to	TO	B-VP	O	
initiate	initiate	VB	I-VP	O	
antimicrobial	antimicrobial	JJ	B-NP	O	
surveillance	surveillance	NN	I-NP	O	
as	as	IN	B-PP	O	
a	a	DT	B-NP	O	
result	result	NN	I-NP	O	
of	of	IN	B-PP	O	
lack	lack	NN	B-NP	O	
of	of	IN	B-PP	O	
resources	resource	NNS	B-NP	O	
.	.	.	O	O	

The	The	DT	B-NP	O	
percentage	percentage	NN	I-NP	O	
of	of	IN	B-PP	O	
penicillin	penicillin	NN	B-NP	B-protein	
-	-	HYPH	O	O	
resistant	resistant	JJ	B-NP	O	
N. gonorrhoeae	N._gonorrhoeae	NNP	I-NP	O	
isolated	isolate	VBN	B-VP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
region	region	NN	I-NP	O	
over	over	IN	B-PP	O	
the	the	DT	B-NP	O	
decade	decade	NN	I-NP	O	
varied	vary	VBD	B-VP	O	
considerably	considerably	RB	B-ADVP	O	
(	(	(	O	O	
1.0-11.9	1.0-11.9	CD	B-NP	O	
%	%	NN	I-NP	O	
carried	carry	VBD	B-VP	O	
chromosomal	chromosomal	JJ	B-NP	O	
resistance	resistance	NN	I-NP	O	
and	and	CC	O	O	
17.9-38.8	17.9-38.8	CD	B-NP	O	
%	%	NN	I-NP	O	
produced	produce	VBN	B-VP	O	
beta	beta	SYM	O	O	
-	-	HYPH	O	O	
lactamase	lactamase	NN	B-NP	O	
)	)	)	O	O	
with	with	IN	B-PP	O	
an	an	DT	B-NP	O	
overall	overall	JJ	I-NP	O	
trend	trend	NN	I-NP	O	
to	to	TO	B-PP	O	
declining	decline	VBG	B-NP	O	
numbers	number	NNS	I-NP	O	
of	of	IN	B-PP	O	
penicillin	penicillin	NN	B-NP	B-protein	
-	-	HYPH	B-NP	O	
resistant	resistant	JJ	I-NP	O	
isolates	isolate	NNS	I-NP	O	
.	.	.	O	O	

For	For	IN	B-PP	O	
tetracycline	tetracycline	NN	B-NP	O	
,	,	,	O	O	
7.4	7.4	CD	B-NP	O	
%	%	NN	I-NP	O	
to	to	TO	B-PP	O	
36.3	36.3	CD	B-NP	O	
%	%	NN	I-NP	O	
carried	carry	VBD	B-VP	O	
chromosomal	chromosomal	JJ	B-NP	O	
resistance	resistance	NN	I-NP	O	
,	,	,	O	O	
whereas	whereas	IN	O	O	
12.0	12.0	CD	B-NP	O	
%	%	NN	I-NP	O	
to	to	TO	B-PP	O	
27.4	27.4	CD	B-NP	B-DNA	
%	%	NN	I-NP	I-DNA	
carried	carry	VBD	B-VP	I-DNA	
plasmid	plasmid	NN	B-NP	I-DNA	
-	-	HYPH	O	O	
mediated	mediate	VBN	B-NP	O	
resistance	resistance	NN	I-NP	O	
.	.	.	O	O	

There	There	EX	B-NP	O	
were	be	VBD	B-VP	O	
no	no	DT	B-NP	O	
reports	report	NNS	I-NP	O	
of	of	IN	B-PP	O	
ciprofloxacin	ciprofloxacin	NN	B-NP	O	
-	-	HYPH	B-NP	O	
resistant	resistant	JJ	I-NP	O	
isolates	isolate	NNS	I-NP	O	
,	,	,	O	O	
although	although	IN	B-SBAR	O	
N. gonorrhoeae	N._gonorrhoeae	NNP	B-NP	O	
with	with	IN	B-PP	O	
decreased	decrease	VBN	B-NP	O	
susceptibility	susceptibility	NN	I-NP	O	
to	to	TO	B-PP	O	
ciprofloxacin	ciprofloxacin	NN	B-NP	O	
and	and	CC	I-NP	O	
azithromycin	azithromycin	NN	I-NP	O	
as	as	RB	B-CONJP	O	
well	well	RB	I-CONJP	O	
as	as	IN	I-CONJP	O	
spectinomycin	spectinomycin	NN	B-NP	O	
-	-	HYPH	B-NP	O	
resistant	resistant	JJ	I-NP	O	
isolates	isolate	NNS	I-NP	O	
were	be	VBD	B-VP	O	
identified	identify	VBN	I-VP	O	
in	in	IN	B-PP	O	
some	some	DT	B-NP	O	
countries	country	NNS	I-NP	O	
.	.	.	O	O	

